Earnings Call · Q3 FY2025·2025-10-30

Q3 25EPS +65.71%·Rev n/aQ2 25EPS +100.00%*·Rev n/aQ1 25EPS +97.30%·Rev n/aQ4 24EPS +100.00%*·Rev n/a⚠ consensus missing

ALNYLAM PHARMACEUTICALS, INC. ALNY

Christine Lindenboom — Chief Corporate Communications Officer

Yvonne Greenstreet — Chief Executive Officer

Tolga Tanguler — Chief Commercial Officer

Pushkal Garg — Chief Research and Development Officer

Jeffrey Poulton — Chief Financial Officer

−6.7%1d on move date−5.6% vs SPY3d−9.9%5d−9.8%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ALNY calls or request research access.

More ALNY calls Browse calls Request research access